The company is developing a revolutionary approach to the local treatment of cancer based on nanoparticles that potentiate the effect of radiotherapy.

Nanobiotix was listed on the stock exchange in 2012.

heads

Laurent LEVY

Philippe MAUBERNA

Anne-Juliette HERMANT